Market Cap 753.51M
Revenue (ttm) 0.00
Net Income (ttm) -68.00M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,175,800
Avg Vol 525,298
Day's Range N/A - N/A
Shares Out 54.52M
Stochastic %K 90%
Beta N/A
Analysts Strong Sell
Price Target $41.40

Latest News on BCAX

Bicara: Innovative Precision Tumor Targeting

Apr 19, 2025, 6:22 AM EDT - 4 days ago

Bicara: Innovative Precision Tumor Targeting


Bicara Therapeutics targets $265 mln proceeds in upsized US IPO

Sep 11, 2024, 6:34 PM EDT - 8 months ago

Bicara Therapeutics targets $265 mln proceeds in upsized US IPO


Bicara Therapeutics IPO Registration Document (S-1)

Aug 22, 2024, 4:38 PM EDT - 8 months ago

Bicara Therapeutics IPO Registration Document (S-1)